The global DNA synthesis market size was accounted for USD 281.11 million in 2022 and it is predicted to expand around USD 513.80 million by 2030 with a CAGR of 7.83% from 2022 to 2030.
The global DNA synthesis market size was accounted for USD 281.11 million in 2022 and it is predicted to expand around USD 513.80 million by 2030 with a CAGR of 7.83% from 2022 to 2030.
The growth of the DNA synthesis market is attributed to factors such as the growing demand for DNA synthesis for its utility in modern applications in molecular biology, genetic engineering, and clinical diagnostics and therapeutics. The growing demand for research in drug discovery and personalized medicine is positively impacting the growth of the market. The COVID-19 pandemic situation has highlighted the utility of mRNA in research and vaccine production.
The mRNA is essentially synthesized in the nucleus using the nucleotide sequence as a template. Moreover, synthetic nucleotides are being used for simulating reactions in the human body to gauge immunity profile, the development of vaccines, and the expansion of gene therapy techniques. For instance, in January 2022, Pfizer entered into a collaboration with Codex for the development of its nucleotide’s short-oligo ligation assembly-based novel enzymatic DNA synthesis technology for potential use by Pfizer in its biopharma products and mRNA-based vaccines.
Get Sample pages of report@ https://www.visionresearchreports.com/report/sample/39798
Emerging advancements in genetic engineering have opened up new ventures for the appropriate engineering of biological systems. DNA writers are essentially genetically encoded devices used for targeted and recurring alterations of nucleotides in living cells. Many market players have developed novel DNA writers for use in nucleotide synthesis processes. The increasing demand for DNA synthesis across the globe is inspiring researchers to discover novel technologies for the same.
Gene synthesis facilitates researchers to choose a specifically desired sequence and design it. Further, gene synthesis is more precise, robust, and cost-effective than molecular cloning and mutagenesis. Moreover, the gene synthesis technique allows for codon optimization, which drastically enhances the efficacy of protein expression. For instance, in June 2022, researchers at the University of New York successfully created an artificial Hox gene that is intended to plan and re-direct the cells for the development of tissues, organelle, or organs using novel synthetic nucleotide technology and genomic engineering expertise in stem cells.
Enzymatic DNA synthesis offers seamless advantages in terms of accessibility and convenience, thereby enhancing the pace and control over iteration with drastically lowered environmental impact. As a result, market players are involved in collaborative efforts to create novel enzymatic DNA synthesis methods. For instance, in April 2022, Codexis, Inc. entered into a collaboration with Molecular Assemblies, Inc. to advance enzyme engineering technologies to deliver unique solutions for the enzymatic creation of nucleotides. The collaboration is intended to use highly evolved DNA polymerase to enable its Fully Enzymatic Synthesis technology.
Market Dynamics
The demand for DNA synthesis is driven by the rising adoption of gene therapy and increasing requirement for gene synthesis products. The synthetic biology segment is the major dominant segment contributing to the growth of DNA synthesis in the market. In addition, Different end use industries of oligonucleotide synthesis and gene synthesis such as antibody discovery, immunology, infectious diseases, food science and synthetic biology are surging the demand for this market. Moreover, continuous advancement and innovation in technology along with increasing research and development activities related to gene synthesis are boosting the demand for this market. Conversely, the extended time for approval for synthesized products may obstruct the growth of the DNA synthesis market.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of dna synthesis. The growth and trends of dna synthesis industry provide a holistic approach to this study.
Key Takeaway:
- By service type, the oligonucleotide DNA synthesis segment has accounted for a revenue share of 56% in 2022.
- By application, the research and development segment has accounted for a revenue share of 41% in 2022.
- By end-use, the biopharmaceutical companies’ segment has accounted for a revenue share of 42% in 2022
- North America has accounted for a revenue share of around 40.5% in 2022.
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/checkout/39798
You can further customize the report@ https://www.visionresearchreports.com/report/customization/39798
Scope of the Report
| Coverage | Details |
| Market Size in 2030 | USD 513.80 Million |
| CAGR | 7.83% |
| Asia Pacific Revenue Share | 21% in 2022 |
| Europe Revenue Share | 25% in 2022 |
| Key Players | Thermo Fisher Scientific, Inc., Twist Bioscience, Bioneer Corporation, Eton Bioscience, LGC Biosearch Technologie, IBA GmbH, Eurofins Scientific, Integrated DNA Technologies, Inc., Quintara Biosciences, GenScript Biotech Corporation, others |
Service Type Insights
The oligonucleotide DNA synthesis segment held the largest share of over 55.0% in 2022. Oligonucleotides are specifically designed with specific base pairs using a strand of nucleotide. They are most usually used as primers and probes for biological processes. The oligonucleotide synthesis technique is a rapid and inexpensive way of producing desired oligonucleotide sequences. Moreover, companies are entering into strategic initiatives to launch novel products, which is expected to drive the segment. For instance, in October 2022, Bachem signed into a collaboration with Eli-Lilly and Company for the development and manufacturing of APIs that are based on oligonucleotides. The collaboration is intended for Bachem to facilitate technical infrastructure and expertise to implement Lilly’s novel oligonucleotide manufacturing technology.
The gene DNA synthesis is anticipated to grow significantly during the forecast period. Custom gene synthesis overcomes the limitations of PCR-based processes. It yields reliable, safe, and cost-effective DNA constructs with verified sequences. Moreover, gene creation is a dependable, inexpensive method for creating highly precise, customized DNA constructs. DNA synthesis has transformed modern biology and is a powerful molecular biology tool that is gradually gaining over the research workflow.
Application Insights
The research and development segment held the largest share of over 40.0% in 2022. DNA is a fundamental tool for biotechnology-based research and trade. An estimate by Synbiobeta states that the global bio-engineering industry uses over 3 kg of nucleotide bases per year for vivid research applications. Synthetic DNA is also very widely used as the template for mRNA-based technologies for the production of vaccines for COVID-19 and cancers. For instance, in November 2021, DNAScript declares that it received a grant of USD 2.2 million from the National Human Genome Research Institute as a support fund for the development of next-generation printers that enzymatically print synthetic nucleotides.
The therapeutics segment is anticipated to grow significantly during the forecast period. Nucleotide synthesis is used to consistently support ongoing therapeutic research studies across the globe. Moreover, the availability of rapid, accurate DNA synthesis enables faster and more effective profiling of a wider range of targets from the capacity to develop synthetic gene circuits to developing and screening enzymes for therapeutic use.
End-use Insights
The biopharmaceutical companies segment held the largest share of over 40.0% in 2022 owing to a rise in the demand for biotechnology-based trade prospects across the globe. Moreover, synthetic nucleotides accelerate the developmental processes of enhanced bio-molecular therapies comprising enzymes, peptides, RNA catalysts, and aptamers. Moreover, companies can now synthesize DNA fragments more quickly, cheaply, and effectively due to the development of nucleotide production techniques and the focus on automation and autonomous technology. DNA synthesis is a fundamental molecular biology procedure that is crucial to many fields, including genetic engineering and clinical diagnosis and treatment. Such factors are expected to drive the segment.
The academic and research institutes segment is anticipated to grow significantly during the forecast period. The synthesis of nucleotides consistently supports ongoing biological research studies across the globe for applications in fields such as genetic engineering and drug discovery.
Regional Insights
North America dominated the global market with a revenue share of over 40.0% in 2022. The demand for synthetic nucleotides in this region is growing due to numerous research initiatives in the region for emerging advancements in biotechnology including the rapid development of therapeutics and vaccines. For instance, in April 2021, DNAScript entered into a collaboration with Moderna along with a USD 5 million grant from the U.S. Defense Advanced Research Projects Agency. The collaboration is intended for the development of a prototype for robust manufacturing of therapeutics and vaccines as part of the global nucleic acids on-demand program.
The Asia Pacific region is anticipated to witness the fastest growth during the forecast period. An increase in support for biological research and drug discovery is boosting the demand for a consistent supply of synthetic nucleotides for utility in research exercises. Numerous ongoing research studies at the research centers across the region and emerging market players are positively impacting the growth of the market.
Related Reports
- Gene Synthesis Market Report 2022 to 2030: https://www.visionresearchreports.com/gene-synthesis-market/39078
- Oligonucleotide Synthesis Market Report 2021-2030: Click Here
- Digital Breast Tomosynthesis Market – Global Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028
- Peptide Synthesis Market Report 2021-2028: Click here to get full access of report
Key Players
- Thermo Fisher Scientific, Inc.
- Twist Bioscience
- Bioneer Corporation
- Eton Bioscience
- LGC Biosearch Technologie
- IBA GmbH
- Eurofins Scientific
- Integrated DNA Technologies, Inc.
- Quintara Biosciences
- GenScript Biotech Corporation
- others
Market Segmentation
By Service Type
- Oligonucleotide Synthesis
- Universal Oligonucleotide Synthesis
- Custom Oligonucleotide Synthesis
- Gene Synthesis
- Custom Gene Synthesis
- Gene Library Synthesis
By Application
- Research and Development
- Academic
- Industrial
- Diagnosis
- Therapeutics
By End User
- Biopharmaceutical Companies
- Academic and Research Institutes
- Contract Research Organizations
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa (MEA)
Frequently Asked Questions
- How prevalent is the DNA synthesis market?
- Which segment accounted for the greatest share of the DNA synthesis market?
- Who are the main players in the DNA synthesis market?
- What factors are propelling the DNA synthesis market?
- What are the leading applications in the DNA synthesis market?
- Which geographical landscape will provide higher profit in the upcoming period?
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/checkout/39798
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://qyresearchmedical.com/